SUNNYVALE, Calif., Jan. 21, 2014 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, is currently showcasing the company's advanced robotic systems for microarray printing and scanning at the Society for Laboratory Automation and Screening Conference in San Diego, California, USA from January 18-22, 2014. Sponsored by Agilent Technologies, Molecular Devices, Thermo Scientific, and other automation leaders, the conference tagline "An exceptional array of answers" highlights the central role of microarray technology in drug discovery and screening, biomarker identification, nanotechnology, bioinformatics and other conference focus areas.
Arrayit's patented and proprietary robotic systems utilize micro-robotics, linear drive technology, nanoliter and picoliter contact dispensing, real-time auto-focusing and other advanced approaches to empower the full spectrum of microarray applications required to explore the human genome and proteome, decipher human illnesses, diagnose diseases pre-symptomatically and identify safer and more efficacious medicines. Arrayit offers its 4,000 worldwide technology installations the advantages of flexibility, affordability and high performance in personal and industrial scale product offerings that are intuitive and readily deployed.
Arrayit completed its most successful year as a public company in 2013 by raising more than $2.2m in equity capital, securing financial advice from small cap expert Irwin Zalcberg, adding biotech expert Sid Taubenfeld to the Board, retaining Phil Ruben as General Counsel, leveraging the investor relations expertise of IMS, moving into a new company headquarters, hiring DOCRO, beginning CLIA and ISO laboratory certification and preparing for OvaDx® FDA submission. The company carries significant momentum into the new fiscal year after recording a company-best 150 qualified sales leads at last week's Plant and Animal Genome Conference.About Arrayit Corporation Arrayit utilizes its patented and proprietary microarray platform to lead and empower the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV